News

Gene therapy firm secures $150M round led by Bain Capital
Atsena Therapeutics has raised $150 million in a round led by Bain Capital, a private investment firm based in Boston. The ...
Healio1mon
FDA grants fast track designation to X-linked retinoschisis treatment
ATSN-201 is being evaluated for the treatment of X-linked retinoschisis ... the surgeon can select more peripheral sites that are unaffected by schisis. Additionally, the surgeon can administer ...